PLUVICTO (lutetium Lu 177 vipivotide tetraxetan)

**Product type:** Human Prescription Drug

**Active ingredient:** LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN

**Strength:** 27 mCi/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** NDA (NDA215833)

**Pharmacologic class:** Radioligand Activity [MoA], Radioligand Therapeutic Agent [EPC]